These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16371301)

  • 1. The optimal analysis of MRI data to quantify the distribution of a microbicide.
    Barnhart KT; Pretorius ES; Shera DM; Shabbout M; Shaunik A
    Contraception; 2006 Jan; 73(1):82-7. PubMed ID: 16371301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL).
    Barnhart KT; Pretorius ES; Shaunik A; Timbers K; Nasution M; Mauck C
    Contraception; 2005 Jul; 72(1):65-70. PubMed ID: 15964295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2004 Dec; 70(6):498-505. PubMed ID: 15541413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ; Schwartz JL; Friend DR; Coleman JS; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1109-15. PubMed ID: 26077739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES; Timbers K; Malamud D; Barnhart K
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline dimensions of the human vagina.
    Barnhart KT; Izquierdo A; Pretorius ES; Shera DM; Shabbout M; Shaunik A
    Hum Reprod; 2006 Jun; 21(6):1618-22. PubMed ID: 16478763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI of the female pelvis using vaginal gel.
    Brown MA; Mattrey RF; Stamato S; Sirlin CB
    AJR Am J Roentgenol; 2005 Nov; 185(5):1221-7. PubMed ID: 16247138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal distribution of Replens and K-Y Jelly using three imaging techniques.
    Mauck CK; Katz D; Sandefer EP; Nasution MD; Henderson M; Digenis GA; Su I; Page R; Barnhart K
    Contraception; 2008 Mar; 77(3):195-204. PubMed ID: 18279691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deeply infiltrating endometriosis: evaluation of retro-cervical space on MRI after vaginal opacification.
    Fiaschetti V; Crusco S; Meschini A; Cama V; Di Vito L; Marziali M; Piccione E; Calabria F; Simonetti G
    Eur J Radiol; 2012 Nov; 81(11):3638-45. PubMed ID: 21813257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of Carraguard vaginal gel use among Thai couples.
    Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
    AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application.
    Haaland RE; Evans-Strickfaden T; Holder A; Pau CP; McNicholl JM; Chaikummao S; Chonwattana W; Hart CE
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3592-6. PubMed ID: 22508307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT; Martin AP; Hazrati E; Garin A; Guzman E; Wilson SS; Porter DD; Lira SA; Keller MJ; Herold BC
    J Infect Dis; 2007 May; 195(9):1332-9. PubMed ID: 17397004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic.
    Brache V; Cohen JA; Cochon L; Alvarez F
    Contraception; 2006 Jan; 73(1):72-7. PubMed ID: 16371299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL; Katz DF
    J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.